Q4’19 – Latest Authorizations by the Regulatory Agencies – Asia
20/01/2020
- Medichem receives the Approval Notice Letter by the Korean Authorities for Apixaban´s Active Pharmaceutical Ingredient – Q4’19
- Medichem´s DMF for Quetiapine´s Active Pharmaceutical Ingredient is filed to the NMPA, China – Q4′ 19
